Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the Expression Level of Th9 Cells and IL-9 In Poor/Non-responsiveness to Hepatitis B Vaccination

NCT01441609 is registered in ClinicalTrials.gov with Beijing Municipal Science & Technology Commission as lead sponsor.

NCT NCT01441609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01441609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the Expression Level of Th9 Cells and IL-9 In Poor/Non-responsiveness to Hepatitis B Vaccination
Lead sponsor
Beijing Municipal Science & Technology Commission
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2011
Completion date
May 31, 2012
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b